Astellas Singapore Pte Ltd

Astellas Singapore Pte Ltd is the Singapore arm of the Japanese pharmaceutical company specialising in urology, oncology, and transplant medicines. Astellas Singapore Pte Ltd manages Singapore commercial operations for Xtandi enzalutamide prostate cancer treatment, Myrbetriq overactive bladder medicine, and Prograf tacrolimus immunosuppressant used in transplant patients. Singapore serves as Astellas’s Southeast Asia hub, supporting its specialist medicine portfolio across urology, oncology, an.